FDA’s advisory panel backs GSK’s RSV vaccine
On Feb. 28, 2023, the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommended approval for Pfizer’s respiratory …
On Feb. 28, 2023, the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommended approval for Pfizer’s respiratory …
The Pfizer RSV vaccine candidate for adults over 60 has been recommended by an advisory committee of the Food and Drug Administration (FDA), and …
FDA panel recommends Pfizer RSV vaccine for older adults Read More »
Pain is the number one reason most Americans go to the doctor is pain, says Cindy Steinberg, Director of Policy and Advocacy for the …
For three decades, Genethon, a non-profit research organization, has pioneered development of gene therapies for rare and ultra-rare diseases. Now that our hard work …
A significant increase in the percentage of Shigella infections caused by extensively drug-resistant (XDR) versions of the bacteria has prompted the U.S. Centers for …
The rise of drug-resistant Shigella offers glimpse into danger AMR poses Read More »
According to a recent report from IQVIA, the market for biosimilars, which mimic innovative biologics, is poised to grow this year. Since 2007, a …
Biosimilars expected to boom in 2023-27, says report Read More »
Starting Veklury (remdesivir) within the first two days of hospitalization for COVID-19 can reduce mortality and decrease readmission rates for all hospitalized patients, regardless …
Gilead’s anti-COVID Veklury reduces risk of death Read More »
Pfizer’s vaccine aimed at protecting infants against severe respiratory syncytial virus (RSV) could roll out as early as this summer as the Food and …
Pfizer’s RSV vaccine for infants could be approved this summer Read More »
“You know,” Karyne Jones laughs, “I am about the same age as many of the people I work with, so the older I get, …
NCBA understands that, in Black America, health care is holistic Read More »
When it comes to long COVID, health care providers and the biotech industry must be aware of what is already known, but we still …
BIO’s long COVID webinar furthers search for biotech solutions Read More »